Patent Assignment
Reel/Frame 064678/0502
Assignment of Assignor's Interest
Recorded: 2023-08-23
Pages: 22
Assignor
BIOGEN CHESAPEAKE LLC
Executed: 2023-08-03
Assignee
REMEDY PHARMACEUTICALS, INC.
233 BROADWAY 17TH FLOOR, NEW YORK, NEW YORK, 10279
Covered Properties
(35)
Liquid Formulations of Compounds Active at Sulfonylurea Receptors
PCT:
PCT/US2009/032455 ↗
Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors
Application:
12/444,908 →
Publication:
US 2010/0056444
Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non-Selective CA++ Activated ATP-Sensitive Cation Channels Regulatd by SUR1 Channels
Methods of Intravenous Administration of Glyburide and Other Drugs
Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
Methods of Intravenous Administration of Glyburide
Methods of Intravenous Administration of Glyburide
Liquid Formulations of Compounds Active at Sulfonylurea Receptors
Methods of Intravenous Administration of Glyburide
Application:
15/422,358 →
Methods of Intravenous Administration of Glyburide
Methods of Reducing or Preventing Intimal Damage Caused by Mechanical Stimulation of Endothelial Cells
Methods of Intravenous Administration of Glyburide
Methods of Treating Injuries or Conditions Related to Cns Edema
Application:
15/763,932 →
Publication:
US 2018/0280325
Composition Containing Glibenclamide
Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
Methods of Medical Treatment with SUR1-TRPM4 Channel Inhibitors
Methods of Treating or Preventing Amyloid Related Imaging Abnormalities Associated with Alzheimer's Disease Treatment
Application:
16/321,240 →
Publication:
US 2019/0167611
Methods of Intravenous Administration of Glyburide
Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
Composition Containing Glibenclamide
Composition Containing Glibenclamide
Application:
17/004,448 →
Publication:
US 2021/0113500
Methods of Intravenous Administration of Glyburide
Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
Application:
17/126,993 →
Publication:
US 2021/0244669
Methods of Treating Injuries or Conditions Related to Cns Edema
Methods of Medical Treatment with SUR1-TRPM4 Channel Inhibitors
Application:
17/542,830 →
Publication:
US 2022/0088039
Methods of Intravenous Administration of Glyburide
Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
Application:
60/992,241 →
Methods of Treating Injuries or Conditions Related to Cns Edema
Application:
62/238,461 →
Methods of Treating or Preventing Amyloid Related Imaging Abnormalities Associated with Alzheimer's Disease Treatment
Application:
62/368,375 →
METHODS OF TREATING OR PREVENTING ADVERSE OUTCOMES ASSOCIATED WITH tPA ADMINISTRATION
Application:
62/368,386 →
Methods of Treating or Preventing Cerebral Edema-Related Side Effects Induced by Medical Treatment
Application:
62/368,411 →
Methods of Treating or Preventing Cerebral Edema Associated with Radiation Therapy
Application:
62/368,422 →
Methods of Treating or Preventing Migraine Headaches with SUR1-TRPM4 Channel Inhibitors
Application:
62/368,436 →
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 21, 2013
From: JACOBSON, SVEN MARTIN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 030063/0786 →
Assignment of Assignor's Interest
Jun 10, 2013
From: JACOBSON, SVEN; ANG, ROBERT
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 030580/0274 →
Assignment of Assignor's Interest
Dec 6, 2013
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 031731/0240 →
Assignment of Assignor's Interest
Dec 17, 2013
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 031799/0107 →
Assignment of Assignor's Interest
Sep 8, 2014
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 033690/0498 →
Assignment of Assignor's Interest
Dec 10, 2014
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 034454/0263 →
Assignment of Assignor's Interest
Jan 7, 2015
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 034653/0273 →
Assignment of Assignor's Interest
Oct 8, 2015
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 036756/0954 →
Assignment of Assignor's Interest
Jun 22, 2017
From: REMEDY PHARMACEUTCALS, INC.
To: BIOGEN CHESAPEAKE LLC
Reel/Frame 042785/0401 →
Assignment of Assignor's Interest
Dec 12, 2017
From: SIMARD, J. MARC
To: UNIVERSITY OF MARYLAND, BALTIMORE
Reel/Frame 044374/0961 →
Assignment of a Joint Undivided Right, Title and Interest
Dec 12, 2017
From: UNIVERSITY OF MARYLAND, BALTIMORE
To: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 044849/0153 →
Assignment of a Joint Undivided Right, Title and Interest
Dec 12, 2017
From: REMEDY PHARMACEUTICALS, INC.
To: BIOGEN CHESAPEAKE, LLC
Reel/Frame 044849/0256 →
Assignment of Assignor's Interest
Dec 12, 2017
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 044849/0185 →
Assignment of Assignor's Interest
Jun 11, 2018
From: JACOBSON, SVEN MARTIN
To: BIOGEN CHESAPEAKE LLC
Reel/Frame 046042/0440 →
Assignment of Assignor's Interest
Mar 7, 2019
From: JACOBSON, SVEN; MACALLISTER, THOMAS
To: BIOGEN CHESAPEAKE LLC
Reel/Frame 048531/0340 →
Assignment of Assignor's Interest
Mar 7, 2019
From: JACOBSON, SVEN; MACALLISTER, THOMAS
To: BIOGEN CHESAPEAKE LLC
Reel/Frame 048531/0394 →